Alteogen Inc. — Investor Relations & Filings
Alteogen Inc. is a biopharmaceutical company focused on the development and commercialization of next-generation biologics. The company's core activities are centered on its proprietary platform technologies. These include Hybrozyme™, a novel recombinant human hyaluronidase (ALT-B4) technology that enables the conversion of intravenous (IV) therapies to subcutaneous (SC) formulations, enhancing patient convenience. Additionally, Alteogen develops long-acting biobetters utilizing its NexP™ fusion technology, proprietary antibody-drug conjugates (ADCs), and antibody biosimilars. The company's pipeline is aimed at creating therapies with enhanced efficacy and delivery methods for serious diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 사업보고서 (2022.12) | 2023-03-20 | Korean | |
| 의결권대리행사권유참고서류 | 2023-03-14 | Korean | |
| [기재정정]의결권대리행사권유참고서류 | 2023-03-14 | Korean | |
| 매출액또는손익구조30%(대규모법인은15%)이상변동 | 2023-03-13 | Korean | |
| 주주총회소집결의 | 2023-03-13 | Korean | |
| 주주총회소집공고 | 2023-03-13 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
12 filings
| |||||
| 8382196 | 사업보고서 (2022.12) | 2023-03-20 | Korean | ||
| 8395131 | 의결권대리행사권유참고서류 | 2023-03-14 | Korean | ||
| 8394685 | [기재정정]의결권대리행사권유참고서류 | 2023-03-14 | Korean | ||
| 8397146 | 매출액또는손익구조30%(대규모법인은15%)이상변동 | 2023-03-13 | Korean | ||
| 8397059 | 주주총회소집결의 | 2023-03-13 | Korean | ||
| 8396922 | 주주총회소집공고 | 2023-03-13 | Korean | ||
| 8396801 | 의결권대리행사권유참고서류 | 2023-03-13 | Korean | ||
| 8408809 | 소송등의제기ㆍ신청(경영권분쟁소송) | 2023-02-28 | Korean | ||
| 8421536 | [기재정정]투자판단관련주요경영사항(ALT-BB4(Tergase) 테르가제주 품목허가 신청) | 2023-02-08 | Korean | ||
| 8421758 | 투자판단관련주요경영사항(ALT-BB4(Tergase) 테르가제주 품목허가 신청) | 2023-02-07 | Korean | ||
| 8426412 | 기업설명회(IR)개최 | 2023-01-25 | Korean | ||
| 8426971 | 기업설명회(IR)개최 | 2023-01-20 | Korean | ||
|
2022
3 filings
| |||||
| 8553723 | 투자판단관련주요경영사항(인간 히알루로니다제 원천 기술(ALT-B4) 라이센스 계약 체결) | 2022-12-30 | Korean | ||
| 8559586 | 주주명부폐쇄기간또는기준일설정 | 2022-12-20 | Korean | ||
| 8563584 | 투자판단관련주요경영사항(ALT-BB4 (Tergase® 테르가제, 재조합 히알루로니다제)의 안전성과 내약성 및 약동학 특성을 평가하기 위한 임상시험(Topline data) 결과) | 2022-12-14 | Korean | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
Alteogen Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/15491/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=15491 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=15491 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=15491 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 15491}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Alteogen Inc. (id: 15491)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.